SKAN Group Future Growth

SKAN Group is forecast to grow earnings and revenue by 18.7% and 16.2% per annum respectively while EPS is expected to grow by 19.6% per annum.

18.7%

Earnings growth rate

19.6%

EPS growth rate

Life Sciences earnings growth	19.8%
Revenue growth rate	16.2%
Future return on equity	n/a
Analyst coverage	Low
Last updated	10 Sep 2024

No updates

Earnings and Revenue Growth Forecasts

LSE:0SKN - Analysts future estimates and past financials data (CHF Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	506	58	32	76	2
12/31/2025	428	46	13	58	2
12/31/2024	369	37	23	63	2
6/30/2024	344	32	-33	14	N/A
3/31/2024	332	29	-30	12	N/A
12/31/2023	320	26	-27	9	N/A
9/30/2023	308	27	-10	19	N/A
6/30/2023	296	27	6	30	N/A
3/31/2023	286	23	19	46	N/A
12/31/2022	277	19	33	61	N/A
9/30/2022	265	13	14	49	N/A
6/30/2022	253	7	-4	37	N/A
3/31/2022	244	9	-18	24	N/A
12/31/2021	234	11	-32	10	N/A
9/30/2021	217	7	-18	15	N/A
6/30/2021	200	3	-3	21	N/A
3/31/2021	196	4	2	22	N/A
12/31/2020	192	5	8	23	N/A
9/30/2020	150	12	1	12	N/A
6/30/2020	109	20	-6	2	N/A
3/31/2020	64	19	-2	2	N/A
12/31/2019	19	18	2	2	N/A
9/30/2019	13	12	2	2	N/A
6/30/2019	7	6	2	2	N/A
3/31/2019	7	6	2	2	N/A
12/31/2018	7	6	2	2	N/A
9/30/2018	11	8	2	2	N/A
6/30/2018	14	9	2	2	N/A
3/31/2018	17	12	N/A	2	N/A
12/31/2017	20	15	N/A	1	N/A
9/30/2017	17	13	N/A	1	N/A
6/30/2017	15	10	N/A	1	N/A
3/31/2017	19	13	N/A	1	N/A
12/31/2016	24	16	N/A	1	N/A
9/30/2016	23	15	N/A	1	N/A
6/30/2016	21	14	N/A	1	N/A
3/31/2016	22	16	N/A	1	N/A
12/31/2015	23	18	N/A	0	N/A
9/30/2015	22	19	N/A	0	N/A
6/30/2015	21	19	N/A	1	N/A
3/31/2015	13	12	N/A	0	N/A
12/31/2014	6	4	N/A	0	N/A
9/30/2014	6	5	N/A	0	N/A
6/30/2014	6	5	N/A	0	N/A
3/31/2014	4	4	N/A	0	N/A
12/31/2013	3	2	N/A	1	N/A

Earnings vs Savings Rate: 0SKN's forecast earnings growth (18.7% per year) is above the savings rate (2.1%).

Earnings vs Market: 0SKN's earnings (18.7% per year) are forecast to grow faster than the UK market (14.6% per year).

High Growth Earnings: 0SKN's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0SKN's revenue (16.2% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: 0SKN's revenue (16.2% per year) is forecast to grow slower than 20% per year.

Future ROE: Insufficient data to determine if 0SKN's Return on Equity is forecast to be high in 3 years time